UBS Group’s GT Biopharma GTBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.8K | Buy |
5,810
+3,251
| +127% | +$11.6K | ﹤0.01% | 7097 |
|
|
2025
Q1 | $5.5K | Sell |
2,559
-2,437
| -49% | -$5.24K | ﹤0.01% | 7669 |
|
|
2024
Q4 | $15.2K | Buy |
4,996
+1,093
| +28% | +$3.33K | ﹤0.01% | 6821 |
|
|
2024
Q3 | $9.01K | Sell |
3,903
-5,078
| -57% | -$11.7K | ﹤0.01% | 6596 |
|
|
2024
Q2 | $25.4K | Buy |
8,981
+7,958
| +778% | +$22.5K | ﹤0.01% | 5998 |
|
|
2024
Q1 | $4.53K | Buy |
1,023
+536
| +110% | +$2.37K | ﹤0.01% | 6442 |
|
|
2023
Q4 | $3.72K | Buy |
487
+195
| +67% | +$1.49K | ﹤0.01% | 6727 |
|
|
2023
Q3 | $2.11K | Buy |
292
+191
| +189% | +$1.38K | ﹤0.01% | 6620 |
|
|
2023
Q2 | $946 | Sell |
101
-159
| -61% | -$1.49K | ﹤0.01% | 6977 |
|
|
2023
Q1 | $4.29K | Buy |
260
+143
| +122% | +$2.36K | ﹤0.01% | 7109 |
|
|
2022
Q4 | $3.14K | Buy |
117
+11
| +10% | +$295 | ﹤0.01% | 8361 |
|
|
2022
Q3 | $5K | Buy |
106
+2
| +2% | +$94 | ﹤0.01% | 8089 |
|
|
2022
Q2 | $9K | Sell |
104
-43
| -29% | -$3.72K | ﹤0.01% | 7094 |
|
|
2022
Q1 | $13K | Sell |
147
-234
| -61% | -$20.7K | ﹤0.01% | 6998 |
|
|
2021
Q4 | $34K | Buy |
381
+222
| +140% | +$19.8K | ﹤0.01% | 6156 |
|
|
2021
Q3 | $32K | Buy |
159
+56
| +54% | +$11.3K | ﹤0.01% | 5573 |
|
|
2021
Q2 | $48K | Sell |
103
-28
| -21% | -$13K | ﹤0.01% | 5409 |
|
|
2021
Q1 | $27K | Buy |
+131
| New | +$27K | ﹤0.01% | 6080 |
|